SOUTH PLAINFIELD, NJ April 30, 2004 PTC Therapeutics, Inc. (PTC), today announced the first identification in humans of an enzyme complex underlying the metabolism of tRNA and mRNA, two integral components of cell proliferation. This research, published in the April 30th issue of the scientific journal Cell, provides compelling evidence for the existence of a new biochemical pathway that may lead to the discovery of new drugs for the treatment of proliferative disorders. Such disorders are characterized by rapidly and uncontrollably dividing cells and include malignancies such as leukemia, lymphoma, multiple myeloma, solid tumors, and inflammatory diseases such as psoriasis.
"The recent work by PTC's researchers is extraordinary in that it creates a physical, and possibly regulatory link between the pathways that create RNA messengers and those that create the translational machinery for turning those messages into proteins," said Dr. David R. Engelke, Director of the Program of Biomedical Sciences at the University of Michigan. "Researchers have always treated these processes as entirely separate sets of reactions. It is now clear that they are intertwined, whether investigating fundamental mechanisms in normal cells or searching for drug targets to identify novel therapeutics."
Dr. Christopher R. Trotta, Senior Scientist at PTC and Principal Investigator in this work comments: "Overexpression of tRNA and mRNA is a key factor in the deregulation of translation that allows cancer cells to grow uncontrollably. This newly discovered biochemical pathway represents an Achilles' Heel of tumor cell growth and opens a new door in the development of therapeutics."
Expression of genetic information is an ordered, multi-step process that proceeds from DNA to RNA to
protein. Deregulation of any step in this process can lead to a number of diseases. Messenger RNA
and transfer RNA are required for the production of proteinPage: 1 2 Related biology news :1
Contact: Kerri Donnelly
908-222-7000 x 112
Euro RSCG Life NRP
. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics2
. Belgian researchers explore revolutionary approach to angiogenesis3
. Award winning researchers reveal potential new role for Glivec4
. $7.5 Million grant to Yale researchers for role of viruses in cancer5
. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers6
. Joslin researchers clarify mechanisms for beta-cell formation7
. Virginia Tech researchers to release findings on Smith River Project8
. Molecular motor myosin VI moves hand over hand, researchers say9
. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy10
. Emory researchers map structure of anti-cancer molecule11
. Leukemia stem cells identified by Stanford researchers